Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Deborah Yurgelun-Todd, PH.D.

TitleLecturer on Psychology in the Department of Psychiatry
InstitutionMcLean Hospital
DepartmentPsychiatry
AddressThe Brain Institute
U of Utah, School of Medicine
383 Colorow Drive
Salt Lake City UT 84108
Phone617/855-3238

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Coon H, Darlington T, Pimentel R, Smith KR, Huff CD, Hu H, Jerominski L, Hansen J, Klein M, Callor WB, Byrd J, Bakian A, Crowell SE, McMahon WM, Rajamanickam V, Camp NJ, McGlade E, Yurgelun-Todd D, Grey T, Gray D. Genetic risk factors in two Utah pedigrees at high risk for suicide. Transl Psychiatry. 2013; 3:e325.
    View in: PubMed
  2. Hwang J, Kim JE, Kaufman MJ, Renshaw PF, Yoon S, Yurgelun-Todd DA, Choi Y, Jun C, Lyoo IK. Enlarged cavum septum pellucidum as a neurodevelopmental marker in adolescent-onset opiate dependence. PLoS One. 2013; 8(10):e78590.
    View in: PubMed
  3. Lopez-Larson M, King JB, McGlade E, Bueler E, Stoeckel A, Epstein DJ, Yurgelun-Todd D. Enlarged thalamic volumes and increased fractional anisotropy in the thalamic radiations in veterans with suicide behaviors. Front Psychiatry. 2013; 4:83.
    View in: PubMed
  4. Churchwell JC, Yurgelun-Todd DA. Age-related changes in insula cortical thickness and impulsivity: Significance for emotional development and decision-making. Dev Cogn Neurosci. 2013 Oct; 6:80-6.
    View in: PubMed
  5. Kim D, Byul Cho H, Dager SR, Yurgelun-Todd DA, Yoon S, Lee JH, Hea Lee S, Lee S, Renshaw PF, Kyoon Lyoo I. Posterior cerebellar vermal deficits in bipolar disorder. J Affect Disord. 2013 Sep 5; 150(2):499-506.
    View in: PubMed
  6. Prescot AP, Renshaw PF, Yurgelun-Todd DA. ?-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers. Drug Alcohol Depend. 2013 May 1; 129(3):232-9.
    View in: PubMed
  7. Sung YH, Carey PD, Stein DJ, Ferrett HL, Spottiswoode BS, Renshaw PF, Yurgelun-Todd DA. Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana. Behav Brain Res. 2013 Jun 1; 246:154-61.
    View in: PubMed
  8. Lopez-Larson MP, King JB, Terry J, McGlade EC, Yurgelun-Todd D. Reduced insular volume in attention deficit hyperactivity disorder. Psychiatry Res. 2012 Oct 30; 204(1):32-9.
    View in: PubMed
  9. Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, Huber RS, Fiedler KK, Harrell RE, Nickerson BR, Kim SE, Jeong EK, Renshaw PF. Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug Alcohol Depend. 2013 Apr 1; 129(1-2):102-9.
    View in: PubMed
  10. Churchwell JC, Carey PD, Ferrett HL, Stein DJ, Yurgelun-Todd DA. Abnormal Striatal Circuitry and Intensified Novelty Seeking among Adolescents Who Abuse Methamphetamine and Cannabis. Dev Neurosci. 2012; 34(4):310-7.
    View in: PubMed
  11. Lopez-Larson MP, Rogowska J, Bogorodzki P, Bueler CE, McGlade EC, Yurgelun-Todd DA. Cortico-cerebellar abnormalities in adolescents with heavy marijuana use. Psychiatry Res. 2012 Jun 30; 202(3):224-32.
    View in: PubMed
  12. Churchwell JC, Lopez-Larson M, Yurgelun-Todd DA. Orbitofrontal cortex and neuromaturation: a gateway to risk? Biol Psychiatry. 2012 Apr 15; 71(8):664-5.
    View in: PubMed
  13. Sneider JT, Sava S, Rogowska J, Yurgelun-Todd DA. A preliminary study of sex differences in brain activation during a spatial navigation task in healthy adults. Percept Mot Skills. 2011 Oct; 113(2):461-80.
    View in: PubMed
  14. Anderson JS, Dhatt HS, Ferguson MA, Lopez-Larson M, Schrock LE, House PA, Yurgelun-Todd D. Functional connectivity targeting for deep brain stimulation in essential tremor. AJNR Am J Neuroradiol. 2011 Nov-Dec; 32(10):1963-8.
    View in: PubMed
  15. Yurgelun-Todd DA, Bueler CE, McGlade EC, Churchwell JC, Brenner LA, Lopez-Larson MP. Neuroimaging correlates of traumatic brain injury and suicidal behavior. J Head Trauma Rehabil. 2011 Jul-Aug; 26(4):276-89.
    View in: PubMed
  16. Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd D. Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers. Exp Clin Psychopharmacol. 2011 Jun; 19(3):231-42.
    View in: PubMed
  17. White RF, Palumbo CL, Yurgelun-Todd DA, Heaton KJ, Weihe P, Debes F, Grandjean P. Functional MRI approach to developmental methylmercury and polychlorinated biphenyl neurotoxicity. Neurotoxicology. 2011 Dec; 32(6):975-80.
    View in: PubMed
  18. Lopez-Larson MP, Anderson JS, Ferguson MA, Yurgelun-Todd D. Local brain connectivity and associations with gender and age. Dev Cogn Neurosci. 2011 Apr; 1(2):187-97.
    View in: PubMed
  19. Silveri MM, Jensen JE, Rosso IM, Sneider JT, Yurgelun-Todd DA. Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res. 2011 Mar 31; 191(3):201-11.
    View in: PubMed
  20. Prescot AP, Locatelli AE, Renshaw PF, Yurgelun-Todd DA. Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage. 2011 Jul 1; 57(1):69-75.
    View in: PubMed
  21. Lopez-Larson MP, Bogorodzki P, Rogowska J, McGlade E, King JB, Terry J, Yurgelun-Todd D. Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav Brain Res. 2011 Jun 20; 220(1):164-72.
    View in: PubMed
  22. Anderson JS, Ferguson MA, Lopez-Larson M, Yurgelun-Todd D. Reproducibility of single-subject functional connectivity measurements. AJNR Am J Neuroradiol. 2011 Mar; 32(3):548-55.
    View in: PubMed
  23. Anderson JS, Ferguson MA, Lopez-Larson M, Yurgelun-Todd D. Connectivity gradients between the default mode and attention control networks. Brain Connect. 2011; 1(2):147-57.
    View in: PubMed
  24. Churchwell JC, Lopez-Larson M, Yurgelun-Todd DA. Altered frontal cortical volume and decision making in adolescent cannabis users. Front Psychol. 2010; 1:225.
    View in: PubMed
  25. Marchand WR, Yurgelun-Todd D. Striatal structure and function in mood disorders: a comprehensive review. Bipolar Disord. 2010 Dec; 12(8):764-85.
    View in: PubMed
  26. Silveri MM, Rogowska J, McCaffrey A, Yurgelun-Todd DA. Adolescents at risk for alcohol abuse demonstrate altered frontal lobe activation during Stroop performance. Alcohol Clin Exp Res. 2011 Feb; 35(2):218-28.
    View in: PubMed
  27. Anderson JS, Ferguson MA, Lopez-Larson M, Yurgelun-Todd D. Topographic maps of multisensory attention. Proc Natl Acad Sci U S A. 2010 Nov 16; 107(46):20110-4.
    View in: PubMed
  28. Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, Kieseppä T, Altshuler LL, Fornito A, Malhi GS, McIntosh AM, Yurgelun-Todd DA, Labar KS, Sharma V, MacQueen GM, Murray RM, McDonald C. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry. 2011 Feb 15; 69(4):326-35.
    View in: PubMed
  29. Kim N, Mickelson JB, Brenner BE, Haws CA, Yurgelun-Todd DA, Renshaw PF. Altitude, gun ownership, rural areas, and suicide. Am J Psychiatry. 2011 Jan; 168(1):49-54.
    View in: PubMed
  30. Anderson JS, Druzgal TJ, Lopez-Larson M, Jeong EK, Desai K, Yurgelun-Todd D. Network anticorrelations, global regression, and phase-shifted soft tissue correction. Hum Brain Mapp. 2011 Jun; 32(6):919-34.
    View in: PubMed
  31. Killgore WD, Yurgelun-Todd DA. Sex differences in cerebral responses to images of high versus low-calorie food. Neuroreport. 2010 Mar 31; 21(5):354-8.
    View in: PubMed
  32. Hooley JM, Gruber SA, Parker HA, Guillaumot J, Rogowska J, Yurgelun-Todd DA. Neural processing of emotional overinvolvement in borderline personality disorder. J Clin Psychiatry. 2010 Aug; 71(8):1017-24.
    View in: PubMed
  33. Killgore WD, Ross AJ, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DA. Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods. Int J Eat Disord. 2010 Jan; 43(1):6-13.
    View in: PubMed
  34. Liu W, Zhu P, Anderson JS, Yurgelun-Todd D, Fletcher PT. Spatial regularization of functional connectivity using high-dimensional Markov random fields. Med Image Comput Comput Assist Interv. 2010; 13(Pt 2):363-70.
    View in: PubMed
  35. Gruber SA, Rogowska J, Yurgelun-Todd DA. Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend. 2009 Nov 1; 105(1-2):139-53.
    View in: PubMed
  36. Haws CA, Gray DD, Yurgelun-Todd DA, Moskos M, Meyer LJ, Renshaw PF. The possible effect of altitude on regional variation in suicide rates. Med Hypotheses. 2009 Oct; 73(4):587-90.
    View in: PubMed
  37. Hooley JM, Gruber SA, Parker HA, Guillaumot J, Rogowska J, Yurgelun-Todd DA. Cortico-limbic response to personally challenging emotional stimuli after complete recovery from depression. Psychiatry Res. 2009 Apr 30; 172(1):83-91.
    View in: PubMed
  38. Killgore WD, Rosso IM, Gruber SA, Yurgelun-Todd DA. Amygdala volume and verbal memory performance in schizophrenia and bipolar disorder. Cogn Behav Neurol. 2009 Mar; 22(1):28-37.
    View in: PubMed
  39. Hooley JM, Gruber SA, Parker HA, Guillaumot J, Rogowska J, Yurgelun-Todd DA. Cortico-limbic response to personally challenging emotional stimuli after complete recovery from depression. Psychiatry Res. 2009 Feb 28; 171(2):106-19.
    View in: PubMed
  40. Silveri MM, Dikan J, Ross AJ, Jensen JE, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DA. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed. 2008 Nov; 21(10):1066-75.
    View in: PubMed
  41. Killgore WD, Gruber SA, Yurgelun-Todd DA. Abnormal corticostriatal activity during fear perception in bipolar disorder. Neuroreport. 2008 Oct 8; 19(15):1523-7.
    View in: PubMed
  42. Chen Y, Grossman ED, Bidwell LC, Yurgelun-Todd D, Gruber SA, Levy DL, Nakayama K, Holzman PS. Differential activation patterns of occipital and prefrontal cortices during motion processing: evidence from normal and schizophrenic brains. Cogn Affect Behav Neurosci. 2008 Sep; 8(3):293-303.
    View in: PubMed
  43. Silveri MM, Tzilos GK, Yurgelun-Todd DA. Relationship between white matter volume and cognitive performance during adolescence: effects of age, sex and risk for drug use. Addiction. 2008 Sep; 103(9):1509-20.
    View in: PubMed
  44. Sneider JT, Pope HG, Silveri MM, Simpson NS, Gruber SA, Yurgelun-Todd DA. Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers. Eur Neuropsychopharmacol. 2008 Aug; 18(8):612-9.
    View in: PubMed
  45. Yurgelun-Todd DA, Rogowska J, Gruber SA, Bogorodzki P, Simpson NS, Irvin RW, Jauregui KA, Strong RA, Rusche JR. Increased amygdala fMRI activation after secretin administration. Exp Clin Psychopharmacol. 2008 Jun; 16(3):191-8.
    View in: PubMed
  46. Sava S, Yurgelun-Todd DA. Functional magnetic resonance in psychiatry. Top Magn Reson Imaging. 2008 Apr; 19(2):71-9.
    View in: PubMed
  47. Pillay SS, Rogowska J, Kanayama G, Gruber S, Simpson N, Pope HG, Yurgelun-Todd DA. Cannabis and motor function: fMRI changes following 28 days of discontinuation. Exp Clin Psychopharmacol. 2008 Feb; 16(1):22-32.
    View in: PubMed
  48. Yurgelun-Todd DA, Sava S, Dahlgren MK. Mood disorders. Neuroimaging Clin N Am. 2007 Nov; 17(4):511-21, ix.
    View in: PubMed
  49. Killgore WD, Yurgelun-Todd DA. The right-hemisphere and valence hypotheses: could they both be right (and sometimes left)? Soc Cogn Affect Neurosci. 2007 Sep; 2(3):240-50.
    View in: PubMed
  50. Gruber SA, Silveri MM, Yurgelun-Todd DA. Neuropsychological consequences of opiate use. Neuropsychol Rev. 2007 Sep; 17(3):299-315.
    View in: PubMed
  51. Yurgelun-Todd DA, Silveri MM, Gruber SA, Rohan ML, Pimentel PJ. White matter abnormalities observed in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord. 2007 Aug; 9(5):504-12.
    View in: PubMed
  52. Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, Tzilos G, Afshar M, Rouse ED, Tian H, Renshaw PF, Ciraulo DA, Yurgelun-Todd DA. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology. 2008 Mar; 33(4):827-36.
    View in: PubMed
  53. Killgore WD, Yurgelun-Todd DA. Neural correlates of emotional intelligence in adolescent children. Cogn Affect Behav Neurosci. 2007 Jun; 7(2):140-51.
    View in: PubMed
  54. Gruber SA, Rosso IM, Yurgelun-Todd D. Neuropsychological performance predicts clinical recovery in bipolar patients. J Affect Disord. 2008 Jan; 105(1-3):253-60.
    View in: PubMed
  55. Killgore WD, Yurgelun-Todd DA. Positive affect modulates activity in the visual cortex to images of high calorie foods. Int J Neurosci. 2007 May; 117(5):643-53.
    View in: PubMed
  56. Yurgelun-Todd D. Emotional and cognitive changes during adolescence. Curr Opin Neurobiol. 2007 Apr; 17(2):251-7.
    View in: PubMed
  57. Heaton KJ, Palumbo CL, Proctor SP, Killiany RJ, Yurgelun-Todd DA, White RF. Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology. 2007 Jul; 28(4):761-9.
    View in: PubMed
  58. Killgore WD, Gruber SA, Yurgelun-Todd DA. Depressed mood and lateralized prefrontal activity during a Stroop task in adolescent children. Neurosci Lett. 2007 Apr 6; 416(1):43-8.
    View in: PubMed
  59. Sim ME, Lyoo IK, Streeter CC, Covell J, Sarid-Segal O, Ciraulo DA, Kim MJ, Kaufman MJ, Yurgelun-Todd DA, Renshaw PF. Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects. Neuropsychopharmacology. 2007 Oct; 32(10):2229-37.
    View in: PubMed
  60. Killgore WD, Yurgelun-Todd DA. Unconscious processing of facial affect in children and adolescents. Soc Neurosci. 2007; 2(1):28-47.
    View in: PubMed
  61. Kuroki N, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Ersner-Hershfield H, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW. Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am J Psychiatry. 2006 Dec; 163(12):2103-10.
    View in: PubMed
  62. Rosso IM, Killgore WD, Cintron CM, Gruber SA, Tohen M, Yurgelun-Todd DA. Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol Psychiatry. 2007 Mar 15; 61(6):743-9.
    View in: PubMed
  63. Sneider JT, Pope HG, Silveri MM, Simpson NS, Gruber SA, Yurgelun-Todd DA. Altered regional blood volume in chronic cannabis smokers. Exp Clin Psychopharmacol. 2006 Nov; 14(4):422-8.
    View in: PubMed
  64. Yurgelun-Todd DA, Killgore WD. Fear-related activity in the prefrontal cortex increases with age during adolescence: a preliminary fMRI study. Neurosci Lett. 2006 Oct 9; 406(3):194-9.
    View in: PubMed
  65. Pillay SS, Rogowska J, Gruber SA, Simpson N, Yurgelun-Todd DA. Recognition of happy facial affect in panic disorder: an fMRI study. J Anxiety Disord. 2007; 21(3):381-93.
    View in: PubMed
  66. Killgore WD, Yurgelun-Todd DA. Affect modulates appetite-related brain activity to images of food. Int J Eat Disord. 2006 Jul; 39(5):357-63.
    View in: PubMed
  67. Pillay SS, Gruber SA, Rogowska J, Simpson N, Yurgelun-Todd DA. fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection. J Affect Disord. 2006 Aug; 94(1-3):173-81.
    View in: PubMed
  68. Salvatore P, Khalsa HM, Hennen J, Tohen M, Yurgelun-Todd D, Casolari F, Depanfilis C, Maggini C, Baldessarini RJ. Psychopathology factors in first-episode affective and non-affective psychotic disorders. J Psychiatr Res. 2007 Nov; 41(9):724-36.
    View in: PubMed
  69. Silveri MM, Rohan ML, Pimentel PJ, Gruber SA, Rosso IM, Yurgelun-Todd DA. Sex differences in the relationship between white matter microstructure and impulsivity in adolescents. Magn Reson Imaging. 2006 Sep; 24(7):833-41.
    View in: PubMed
  70. Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May; 14(2):157-64.
    View in: PubMed
  71. Joffe H, Hall JE, Gruber S, Sarmiento IA, Cohen LS, Yurgelun-Todd D, Martin KA. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006 May-Jun; 13(3):411-22.
    View in: PubMed
  72. Yurgelun-Todd DA, Ross AJ. Functional magnetic resonance imaging studies in bipolar disorder. CNS Spectr. 2006 Apr; 11(4):287-97.
    View in: PubMed
  73. Killgore WD, Yurgelun-Todd DA. Ventromedial prefrontal activity correlates with depressed mood in adolescent children. Neuroreport. 2006 Feb 6; 17(2):167-71.
    View in: PubMed
  74. Yurgelun-Todd DA, Ross AJ. Functional MRI studies in bipolar disorder. CNS Spectrums. 2006.
  75. Yurgelun-Todd DA, Renshaw PF . Use of Secretin in Treatments of Disorders Associated with the Amygdala. 2006.
  76. Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl). 2006 Jan; 184(2):139-44.
    View in: PubMed
  77. Killgore WD, Yurgelun-Todd DA. Developmental changes in the functional brain responses of adolescents to images of high and low-calorie foods. Dev Psychobiol. 2005 Dec; 47(4):377-97.
    View in: PubMed
  78. Bonelli RM, Kapfhammer HP, Pillay SS, Yurgelun-Todd DA. Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years? J Neural Transm. 2006 Feb; 113(2):255-68.
    View in: PubMed
  79. Killgore WD, Yurgelun-Todd DA. Social anxiety predicts amygdala activation in adolescents viewing fearful faces. Neuroreport. 2005 Oct 17; 16(15):1671-5.
    View in: PubMed
  80. Halpern JH, Sherwood AR, Hudson JI, Yurgelun-Todd D, Pope HG. Psychological and cognitive effects of long-term peyote use among Native Americans. Biol Psychiatry. 2005 Oct 15; 58(8):624-31.
    View in: PubMed
  81. Martin PI, Naeser MA, Doron KW, Bogdan A, Baker EH, Kurland J, Renshaw P, Yurgelun-Todd D. Overt naming in aphasia studied with a functional MRI hemodynamic delay design. Neuroimage. 2005 Oct 15; 28(1):194-204.
    View in: PubMed
  82. Rogowska J, Bogorodzki P, Yurgelun-Todd D. Diagnostic classification based on regional fMRI activation patterns during the perception of facial affect. Conference on Human Brain Mapping. 2005.
  83. Rogowska J, Bogorodzki P, Rohan M, Renshaw P, Yurgelun-Todd D. Experimental phantom system for MR perfusion measurements on the 3T MR scanner. Conference on Human Brain Mapping. 2005.
  84. Killgore WD, Yurgelun-Todd DA. Body mass predicts orbitofrontal activity during visual presentations of high-calorie foods. Neuroreport. 2005 May 31; 16(8):859-63.
    View in: PubMed
  85. Silveri MM, Rohan ML, Pimentel PJ, Gruber SA, Rosso IM, Yurgelun-Todd DA. . Sex differences in the relationship between frontal white matter microstructure and impulsivity in adolescents. International Society for Magnetic Resonance in Medicine. 2005.
  86. Gruber SA, Yurgelun-Todd DA. Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Res Cogn Brain Res. 2005 Apr; 23(1):107-18.
    View in: PubMed
  87. Hooley JM, Gruber SA, Scott LA, Hiller JB, Yurgelun-Todd DA. Activation in dorsolateral prefrontal cortex in response to maternal criticism and praise in recovered depressed and healthy control participants. Biol Psychiatry. 2005 Apr 1; 57(7):809-12.
    View in: PubMed
  88. Bogorodzki P, Rogowska J, Yurgelun-Todd DA. Structural group classification technique based on regional fMRI BOLD responses. IEEE Trans Med Imaging. 2005 Mar; 24(3):389-98.
    View in: PubMed
  89. Yurgelun-Todd DA, Coyle JT, Gruber SA, Renshaw PF, Silveri MM, Amico E, Cohen B, Goff DC. Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine. Psychiatry Res. 2005 Jan 30; 138(1):23-31.
    View in: PubMed
  90. Tzilos GK, Cintron CB, Wood JB, Simpson NS, Young AD, Pope HG, Yurgelun-Todd DA. Lack of hippocampal volume change in long-term heavy cannabis users. Am J Addict. 2005 Jan-Feb; 14(1):64-72.
    View in: PubMed
  91. Yurgelun-Todd D, Sneider JT. Neurocognitive deficits in bipolar disorder [Review]. Clinical Approaches in Bipolar Disorder. 2005; In press.
  92. Silveri MM, Rogowska J, Young AD, Gruber SA, Yurgelun-Todd DA. Frontal activation during Stroop performance in adolescents at risk for substance abuse: An fMRI investigation. Society for Neuroscience. 2005.
  93. Rosso IM, Cintron CM, Steingard RJ, Renshaw PF, Young AD, Yurgelun-Todd DA. Amygdala and hippocampus volumes in pediatric major depression. Biol Psychiatry. 2005 Jan 1; 57(1):21-6.
    View in: PubMed
  94. Sneider JT, Pope HG, Silveri MM, Rosso IM, Gruber SA, Yurgelun-Todd DA . Altered regional blood volume in chronic marijuana smokers. Society for Neuroscience Abstracts. 2005.
  95. Olson D, Coyle J, Ke K, Gruber S, Rosso I, Silveri M, Renshaw P,Yurgelun-Todd D. Two-dimensional J-resolved magnetic resonance spectroscopy (2D J-MRS) in schizophrenia. International Congress on Schizophrenia Research. 2005.
  96. Carey P, de Wit R, Seedat S, Stein D, Silveri M, Yurgelun-Todd D. Functional magnetic resonance imaging (fMRI) of cannabis and cannabis/methaqualone abusers, their discordant siblings and normal controls. College on Problems of Drug Dependence. 2005.
  97. Pillay SS, Rogowska J, Kanayama G, Jon DI, Gruber S, Simpson N, Cherayil M, Pope HG, Yurgelun-Todd DA. Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study. Drug Alcohol Depend. 2004 Dec 7; 76(3):261-71.
    View in: PubMed
  98. Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Dec; 28(8):1313-22.
    View in: PubMed
  99. Kasai K, McCarley RW, Salisbury DF, Onitsuka T, Demeo S, Yurgelun-Todd D, Kikinis R, Jolesz FA, Shenton ME. Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophr Res. 2004 Nov 1; 71(1):65-76.
    View in: PubMed
  100. Gruber SA, Rogowska J, Yurgelun-Todd DA. Decreased activation of the anterior cingulate in bipolar patients: an fMRI study. J Affect Disord. 2004 Oct 15; 82(2):191-201.
    View in: PubMed
  101. Killgore WD, Yurgelun-Todd DA. Sex-related developmental differences in the lateralized activation of the prefrontal cortex and amygdala during perception of facial affect. Percept Mot Skills. 2004 Oct; 99(2):371-91.
    View in: PubMed
  102. Silveri MM, Pollack MH, Diaz CI, Nassar LE, Mendelson JH, Yurgelun-Todd DA, Renshaw PF, Kaufman MJ. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Res. 2004 Sep 15; 131(3):217-26.
    View in: PubMed
  103. Halpern JH, Pope HG, Sherwood AR, Barry S, Hudson JI, Yurgelun-Todd D. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug Alcohol Depend. 2004 Aug 16; 75(2):135-47.
    View in: PubMed
  104. Kanayama G, Rogowska J, Pope HG, Gruber SA, Yurgelun-Todd DA. Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl). 2004 Nov; 176(3-4):239-47.
    View in: PubMed
  105. Silveri MM, Tzilos GK, Pimentel PJ, Yurgelun-Todd DA. Trajectories of adolescent emotional and cognitive development: effects of sex and risk for drug use. Ann N Y Acad Sci. 2004 Jun; 1021:363-70.
    View in: PubMed
  106. Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry. 2004 Jun; 161(6):985-95.
    View in: PubMed
  107. Rosso IM, Young AD, Femia LA, Yurgelun-Todd DA. Cognitive and emotional components of frontal lobe functioning in childhood and adolescence. Ann N Y Acad Sci. 2004 Jun; 1021:355-62.
    View in: PubMed
  108. Naeser MA, Martin PI, Baker EH, Hodge SM, Sczerzenie SE, Nicholas M, Palumbo CL, Goodglass H, Wingfield A, Samaraweera R, Harris G, Baird A, Renshaw P, Yurgelun-Todd D. Overt propositional speech in chronic nonfluent aphasia studied with the dynamic susceptibility contrast fMRI method. Neuroimage. 2004 May; 22(1):29-41.
    View in: PubMed
  109. Ke Y, Streeter CC, Nassar LE, Sarid-Segal O, Hennen J, Yurgelun-Todd DA, Awad LA, Rendall MJ, Gruber SA, Nason A, Mudrick MJ, Blank SR, Meyer AA, Knapp C, Ciraulo DA, Renshaw PF. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res. 2004 Apr 30; 130(3):283-93.
    View in: PubMed
  110. Rogowska J, Gruber SA, Yurgelun-Todd DA. Functional magnetic resonance imaging in schizophrenia: cortical response to motor stimulation. Psychiatry Res. 2004 Apr 30; 130(3):227-43.
    View in: PubMed
  111. Killgore WD, Yurgelun-Todd DA. Activation of the amygdala and anterior cingulate during nonconscious processing of sad versus happy faces. Neuroimage. 2004 Apr; 21(4):1215-23.
    View in: PubMed
  112. Silveri MM, Rohan ML, Pimentel PJ, Gruber SA, Yurgelun-Todd DA . Reduced fractional anisotropy in patients with bipolar disorder: A DTI study. Biol Psychiatry. 2004; 55(8 Suppl 1):31.
  113. Irvin RW, Pillay SS, Yurgelun-Todd DA . Clinical correlates of aggression in first episode psychosis. Biol Psychiatry. 2004; 55(8 Suppl 1):38.
  114. Rosso IM, Young AD, Femia LA, Yurgelun-Todd DA. Cognitive and emotional components of frontal lobe functioning in childhood and adolescence. Proc Natl Acad Sci. 2004; 1021:1-8.
  115. Nordenson B, Gruber SA, Yurgelun-Todd DA. Neurocognition in bipolar disorder: A review of the current research [Review]. Curr Psychosis Therapeutic Repts. 2004; 2:147-52.
  116. Yurgelun-Todd DA. Abnormal Brain Functions in Psychosis: Lessons from Functional Imaging. Integration of Imaging Strategies in Neuroradiology. 2004.
  117. Kurland J, Naeser MA, Baker EH, Doron K, Martin PI, Seekins HE, Bogdan A, Renshaw P, Yurgelun-Todd D. Test-retest reliability of fMRI during nonverbal semantic decisions in moderate-severe nonfluent aphasia patients. Behav Neurol. 2004; 15(3-4):87-97.
    View in: PubMed
  118. Pillay SS, Gruber SA, Rogowska J, Simpson N, Yurgelun-Todd DA. Frontal systems implicated in dysregulation of attention in panic disorder: An fMRI Study. Biol Psychiatry. 2004; 55(8 Suppl 1):1.
  119. Yurgelun-Todd DA, Tohen MF, Risser R, Wei H, Gruber SA. Improved cognitive outcome with olanzapine treatment in bipolar patients. 57th Annual Meeting of the American Psychiatric Association. 2004.
  120. Pope HG, Yurgelun-Todd DA. Cannabis and Cognition. Castle D, Murray R, editors. Marijuana and Madness. 2004; 198-210.
  121. Kasai K, Shenton ME, Salisbury DF, Onitsuka T, Toner SK, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW. Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry. 2003 Nov; 60(11):1069-77.
    View in: PubMed
  122. Gruber AJ, Pope HG, Hudson JI, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med. 2003 Nov; 33(8):1415-22.
    View in: PubMed
  123. Belmonte MK, Yurgelun-Todd DA. Functional anatomy of impaired selective attention and compensatory processing in autism. Brain Res Cogn Brain Res. 2003 Oct; 17(3):651-64.
    View in: PubMed
  124. Ganis G, Kosslyn SM, Stose S, Thompson WL, Yurgelun-Todd DA. Neural correlates of different types of deception: an fMRI investigation. Cereb Cortex. 2003 Aug; 13(8):830-6.
    View in: PubMed
  125. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Spencer MH, Yurgelun-Todd DA, Kikinis R, Jolesz FA, McCarley RW. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry. 2003 Aug; 60(8):766-75.
    View in: PubMed
  126. Killgore WD, Young AD, Femia LA, Bogorodzki P, Rogowska J, Yurgelun-Todd DA. Cortical and limbic activation during viewing of high- versus low-calorie foods. Neuroimage. 2003 Aug; 19(4):1381-94.
    View in: PubMed
  127. Belmonte MK, Yurgelun-Todd DA. Anatomic dissociation of selective and suppressive processes in visual attention. Neuroimage. 2003 May; 19(1):180-9.
    View in: PubMed
  128. Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend. 2003 Apr 1; 69(3):303-10.
    View in: PubMed
  129. Rosso IM, Gruber SA, Yurgelun-Todd DA. Temporal lobe NAA in first episode schizophrenia and bipolar disorder: Preliminary evidence of diagnostic specificity. International Congress on Schizophr Res Colorado Springs, CO. 2003.
  130. Yurgelun-Todd DA, Killgore WD, Cintron CB. Cognitive correlates of medial temporal lobe development across adolescence: a magnetic resonance imaging study. Percept Mot Skills. 2003 Feb; 96(1):3-17.
    View in: PubMed
  131. Renshaw PF, Yurgelun-Todd DA, Wei H, Charles HC, Tohen M, Lieberman JA. Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis. Schizophr Res. 2003; 60(1 Suppl 1):301.
  132. Gruber, SA, Silveri MM, Tzilos GK, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. College on Problems of Drug Dependence. 2003; 61:242.
  133. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry. 2003 Jan; 160(1):156-64.
    View in: PubMed
  134. Yurgelun-Todd DA, Renshaw PF, Wei H, Keefe RSE, Charles HC, Tohen M, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Gur RC, Tollefson GD, Lieberman JA. Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis. Biol Psychiatry. 2003; 53(8 Suppl 1):156.
  135. Rogowska J, Yurgelun-Todd DA. Activation in the motor cortex in schizophrenia investigated by functional MR imaging. Human Brain Mapping: Available on CD-Rom in NeuroImage. 2003; 19(2 Suppl 1).
  136. Glod CA, Lynch A, Young A, Femia L, Yurgelun-Todd DA. Effect of antidepressant treatment on amygdala activation in depressed adolescents. Biol Psychiatry. 2003; 53(8 Suppl 1):140.
  137. Olson DP, Streeter CC, Ke Y, Nassar LE, Sarid-Segal O, Gruber SA, Yurgelun-Todd DA, Lukas SE, Ciraulo DA, Renshaw PF. Normalization of reduced NAA relaxation times in cocaine users after treatment. College on Problems of Drug Dependence: Sixty-Fifth Annual Scientific Meeting. 2003; 512:128.
  138. Katz D, Yurgelun-Todd DA. Gender differences in memory for emotionally laden words in a negative story. J Int Neuropsychol Soc. 2003; 9(2):221.
  139. Renshaw PF, Yurgelun-Todd DA, Wei H, Charles HC, Tohen M, Sharma T, Zipursky RB, Kahn R, Gur RE, Green AL, McEvoy JP, Perkins DO, Hamer RM, Nemeroff CB, Rothschild AJ, Kuldau JM, Strakowski SM, Tollefson GD, Lieberman JA. Olanzapine induced reductions in frontal lobe lactate levels correlate with treatment response in first episode psychosis. Biol Psychiatry. 2003; 53(8 Suppl 1):67.
  140. Yurgelun-Todd DA, Rogowska J, Gruber S, Rioux P, Goulet M, Herlihy W, Rusche J. Increased amygdala fMRI activation after secretin administration. Biol Psychiatry. 2003; 53(8 Suppl 1):213.
  141. Ahn MS, Yugelun-Todd DA, Gruber SA, Frazier J. Brain functional magnetic resonance imaging in children with ADHD. Scientific proceedings of the American Academy of Child and Adolescent Psychiatry. 2003.
  142. Yurgelun-Todd DA, Renshaw PF, Wei H, Keefe RS, Charles HC, Tohen M, Lieberman JA. Improved attention is associated with reductions in frontal lobe lactate levels in first episode psychosis. Schizophr Res. 2003; 60(1 Suppl 1):318.
  143. Olson DP, Hirashima F, Yurgelun-Todd DA, Renshaw PF. [Abstract]. 2003;60(1 Suppl 1):244. . Relaxation effects in quantitative MRS in schizophrenia. Schizophr Res. 2003; 60(1 Suppl 1):244.
  144. Moore CM, Glod C, Femia L, Seifert K, Frazier J, Yurgelun-Todd DA, Renshaw P . Magnetic resonance spectroscopy at 4.0 T of depressed children and adolescents. Scientific proceedings of the Am Acad Child Adolesc Psychiatry. 2003.
  145. Ke Y, Coyle JT, Simpson NS, Gruber SA, Rosso IM, Bogorodzki P, Renshaw PF, Yurgelun-Todd DA. Prefrontal PCr/Cr levels indicate reduced energy demand on schizophrenic brains. Proceed of Int Soc Magnetic Reson Medicine. 2003.
  146. Glod CA, Lynch A, Young A, Femia L, Rogowska J, Yurgelun Todd DA. Functional magnetic imaging in depressed versus normal adolescents. Scientific proceedings of the Am Acad Child Adolesc Psychiatry. 2003.
  147. Ke Y, Coyle JT, Gruber SA, Rosso IR, Simpson NS, Renshaw PF, Yurgelun-Todd DA. [Abstract]. 2003; 60(1 Suppl 1):242. Frontal NAA T2 values are significantly lower in schizophrenia. Schizophr Res. 2003; 60(1 Suppl 1):242.
  148. Yurgelun-Todd DA, Killgore WD, Young AD. Sex differences in cerebral tissue volume and cognitive performance during adolescence. Psychol Rep. 2002 Dec; 91(3 Pt 1):743-57.
    View in: PubMed
  149. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. J Clin Pharmacol. 2002 Nov; 42(11 Suppl):41S-47S.
    View in: PubMed
  150. Lee CU, Shenton ME, Salisbury DF, Kasai K, Onitsuka T, Dickey CC, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW. Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry. 2002 Sep; 59(9):775-81.
    View in: PubMed
  151. Steingard RJ, Renshaw PF, Hennen J, Lenox M, Cintron CB, Young AD, Connor DF, Au TH, Yurgelun-Todd DA. Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry. 2002 Sep 1; 52(5):413-7.
    View in: PubMed
  152. Gruber SA, Rogowska J, Holcomb P, Soraci S, Yurgelun-Todd D. Stroop performance in normal control subjects: an fMRI study. Neuroimage. 2002 Jun; 16(2):349-60.
    View in: PubMed
  153. McCarley RW, Salisbury DF, Hirayasu Y, Yurgelun-Todd DA, Tohen M, Zarate C, Kikinis R, Jolesz FA, Shenton ME. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. Arch Gen Psychiatry. 2002 Apr; 59(4):321-31.
    View in: PubMed
  154. Babb SM, Wald LL, Cohen BM, Villafuerte RA, Gruber SA, Yurgelun-Todd DA, Renshaw PF. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology (Berl). 2002 May; 161(3):248-54.
    View in: PubMed
  155. Goff DC, Hennen J, Lyoo IK, Tsai G, Wald LL, Evins AE, Yurgelun-Todd DA, Renshaw PF. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biol Psychiatry. 2002 Mar 15; 51(6):493-7.
    View in: PubMed
  156. Loeber RT, Gruber SA, Cohen BM, Renshaw PF, Sherwood AR, Yurgelun-Todd DA. Cerebellar blood volume in bipolar patients correlates with medication. Biol Psychiatry. 2002 Mar 1; 51(5):370-6.
    View in: PubMed
  157. Silveri MM, Pollack MH, Diaz CI, Nassar LE, Mendelson JH, Yurgelun-Todd DA, Renshaw PF, Kaufman MJ. Cerebral bioenergetic changes at onset of methadone maintenance treatment in heroin-dependent polydrug abusers. Drug Alcohol Depend. 2002; 66((Suppl 1)):164-5.
  158. Femia LA, Young AD, Renshaw PF, Steingard RJ, Yurgelun-Todd DA. Cerebellar volume abnormalities and their relation to affect. International Meeting on Autism Research. 2002.
  159. Rogowska J, Bogorodzki P, Yurgelun-Todd DA. Multivariate analysis of fMRI BOLD activation in abstinent long-term marijuana smokers. European Society for Magnetic Resonance in Medicine and Biology. 2002.
  160. Frumin M, Golland P, Kikinis R, Hirayasu Y, Salisbury DF, Hennen J, Dickey CC, Anderson M, Fischer IA, Yurgelun-Todd DA, Jolesz FA, Grimson WE, McCarley RW, Shenton ME. Shape differences in the corpus callosum in first psychotic episode schizophrenia and first psychotic episode affective disorder. Am J Psychiatry. 2002; 159(5):866-8.
  161. Moore CM, Bonello CM, Sherwood AR, Cohen BM, Renshaw PF, Yurgelun-Todd DA. Alternation in the left temporal lobe of chronic schizophrenics. Schizophr Res. 2002; 57(1):35-42.
  162. Yurgelun-Todd DA, Gruber SA. Magnetic resonance methods for the study of psychopathology. Maher BA, Lenzenweger MF, Hooley JM, editors. Principles of Experimental Psychopathology. 2002; 211-28.
  163. Irvin RW, Yurgelun-Todd DA. Nonspecific MRI findings in first episode bipolar disorder: Relationship to age at onset and outcome. Bipolar Global Medical Conference. 2002.
  164. Katz D, Killgore WDS, Yurgelun-Todd DA. Bilateral activation of the prefrontal cortex in perception of negative and positive emotion in children and adolescents. Society for Neuroscience Annual Meeting Abstracts. 2002.
  165. Ke Y, Streeter CC, Lowen S, Nassar LE, Hennen J, Yurgelun-Todd DA, Sarid-Segal O, Awad LA, Rendall M, Gruber SA, Nason A, Mudrick MJ, Blank SR, Ciraulo DA, Renshaw PF. Decreased frontal lobe phosphocreatine levels during treatment for cocaine dependence are associated with treatment failure. Drug Alcohol Depend. 2002; 66((Suppl 1)):91.
  166. Pope HG, Gruber AJ, Yurgelun-Todd D. Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep. 2001 Dec; 3(6):507-12.
    View in: PubMed
  167. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry. 2001 Oct; 58(10):909-15.
    View in: PubMed
  168. Cohen BM, Yurgelun-Todd D. Alterations of thalamic activity in schizophrenia and in response to antipsychotic drugs: studies in the legacy of Seymour S. Kety. Neuropsychopharmacology. 2001 Sep; 25(3):305-12.
    View in: PubMed
  169. Killgore WD, Yurgelun-Todd DA. Sex differences in amygdala activation during the perception of facial affect. Neuroreport. 2001 Aug 8; 12(11):2543-7.
    View in: PubMed
  170. Loeber RT, Cintron CM, Yurgelun-Todd DA. Morphometry of individual cerebellar lobules in schizophrenia. Am J Psychiatry. 2001 Jun; 158(6):952-4.
    View in: PubMed
  171. Hirayasu Y, Tanaka S, Shenton ME, Salisbury DF, DeSantis MA, Levitt JJ, Wible C, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW. Prefrontal gray matter volume reduction in first episode schizophrenia. Cereb Cortex. 2001 Apr; 11(4):374-81.
    View in: PubMed
  172. Belmonte M, Yurgelun-Todd D. Permutation testing made practical for functional magnetic resonance image analysis. IEEE Trans Med Imaging. 2001 Mar; 20(3):243-8.
    View in: PubMed
  173. Killgore WD, Oki M, Yurgelun-Todd DA. Sex-specific developmental changes in amygdala responses to affective faces. Neuroreport. 2001 Feb 12; 12(2):427-33.
    View in: PubMed
  174. Cohen BM, Yurgelun-Todd DA. Alterations in thalamic activity in schizophrenics and in response to antipsychotic drugs: Studies in the legacy of Seymour S. Kety. Neuropsychopharmacol. 2001; 25(3):305-12.
  175. Steingard RJ, Yurgelun-Todd DA, Hennen J, Moore JC, Moore CM, Vakili K, Young AD, Katic A, Beardslee WR, Renshaw PF. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biol Psychiatry. 2000 Dec 1; 48(11):1053-61.
    View in: PubMed
  176. Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry. 2000 Sep 15; 48(6):505-17.
    View in: PubMed
  177. Quattrocki E, Baird A, Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry. 2000 Sep; 8(3):99-110.
    View in: PubMed
  178. Moore CM, Breeze JL, Gruber SA, Babb SM, Frederick BB, Villafuerte RA, Stoll AL, Hennen J, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord. 2000 Sep; 2(3 Pt 2):207-16.
    View in: PubMed
  179. Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD. fMRI during affect discrimination in bipolar affective disorder. Bipolar Disord. 2000 Sep; 2(3 Pt 2):237-48.
    View in: PubMed
  180. Killgore WD, Casasanto DJ, Yurgelun-Todd DA, Maldjian JA, Detre JA. Functional activation of the left amygdala and hippocampus during associative encoding. Neuroreport. 2000 Jul 14; 11(10):2259-63.
    View in: PubMed
  181. Hirayasu Y, McCarley RW, Salisbury DF, Tanaka S, Kwon JS, Frumin M, Snyderman D, Yurgelun-Todd D, Kikinis R, Jolesz FA, Shenton ME. Planum temporale and Heschl gyrus volume reduction in schizophrenia: a magnetic resonance imaging study of first-episode patients. Arch Gen Psychiatry. 2000 Jul; 57(7):692-9.
    View in: PubMed
  182. Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, Yurgelun-Todd DA. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry. 2000 Jun 15; 47(12):1087-90.
    View in: PubMed
  183. Manschreck TC, Maher BA, Candela SF, Redmond D, Yurgelun-Todd D, Tsuang M. Impaired verbal memory is associated with impaired motor performance in schizophrenia: relationship to brain structure. Schizophr Res. 2000 May 25; 43(1):21-32.
    View in: PubMed
  184. Yurgelun-Todd DA, Renshaw PF . Magnetic resonance spectroscopy in childhood psychiatric disorders. Ernst M, Rumsey JM, editors. Functional Neuroimaging in Child Psychiatry. 2000; 59-77.
  185. Kinney DK, Steingard RJ, Renshaw PF, Yurgelun-Todd DA. Perinatal complications and abnormal proton metabolite concentrations in frontal cortex of adolescents seen on magnetic resonance spectroscopy. Neuropsychiatry Neuropsychol Behav Neurol. 2000 Jan; 13(1):8-12.
    View in: PubMed
  186. Christensen JD, Yurgelun-Todd DA, Babb SM, Gruber SA, Cohen BM, Renshaw PF. Measurement of human brain dexfenfluramine concentration by 19F magnetic resonance spectroscopy. Brain Res. 1999 Jul 10; 834(1-2):1-5.
    View in: PubMed
  187. Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS, Wible CG, Fischer IA, Yurgelun-Todd D, Zarate C, Kikinis R, Jolesz FA, McCarley RW. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 1999 Jul; 156(7):1091-3.
    View in: PubMed
  188. Loeber RT, Sherwood AR, Renshaw PF, Cohen BM, Yurgelun-Todd DA. Differences in cerebellar blood volume in schizophrenia and bipolar disorder. Schizophr Res. 1999 May 4; 37(1):81-9.
    View in: PubMed
  189. Kinney DK, Levy DL, Yurgelun-Todd DA, Lajonchere CM, Holzman PS. Eye-tracking dysfunction and birth-month weather in schizophrenia. J Abnorm Psychol. 1999 May; 108(2):359-62.
    View in: PubMed
  190. Yurgelun-Todd DA, Renshaw PF. Applications of functional MR imaging to research in psychiatry. Neuroimaging Clin N Am. 1999 May; 9(2):295-308.
    View in: PubMed
  191. Baird AA, Gruber SA, Fein DA, Maas LC, Steingard RJ, Renshaw PF, Cohen BM, Yurgelun-Todd DA. Functional magnetic resonance imaging of facial affect recognition in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999 Feb; 38(2):195-9.
    View in: PubMed
  192. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurologic signs of cerebellar and cortical sensory dysfunction in schizophrenics and their relatives. Schizophr Res. 1999 Jan 11; 35(2):99-104.
    View in: PubMed
  193. Loeber RT, Yurgelun-Todd DA. Human neuroimaging of acute and chronic marijuana use: Implications for frontocerebellar dysfunction. Hum Psychopharmacol Clin Experiment. 1999; 14:291-304.
  194. Gruber SA, Yurgelun-Todd, DA . Neuropsychological Correlates of Substance Abuse. Kaufman MJ, editors. Brain Imaging in Substance Abuse: Research, Clinical and Forensic Applications. 1999; 199-230.
  195. Pillay SS, Renshaw PF, Bonello CM, Lafer BC, Fava M, Yurgelun-Todd D. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Psychiatry Res. 1998 Dec 14; 84(2-3):61-74.
    View in: PubMed
  196. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol. 1998 Oct; 19(9):1727-32.
    View in: PubMed
  197. Hirayasu Y, Shenton ME, Salisbury DF, Dickey CC, Fischer IA, Mazzoni P, Kisler T, Arakaki H, Kwon JS, Anderson JE, Yurgelun-Todd D, Tohen M, McCarley RW. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry. 1998 Oct; 155(10):1384-91.
    View in: PubMed
  198. Maher BA, Manschreck TC, Yurgelun-Todd DA, Tsuang MT. Hemispheric asymmetry of frontal and temporal gray matter and age of onset in schizophrenia. Biol Psychiatry. 1998 Sep 15; 44(6):413-7.
    View in: PubMed
  199. Levine JB, Gruber SA, Baird AA, Yurgelun-Todd D. Obsessive-compulsive disorder among schizophrenic patients: an exploratory study using functional magnetic resonance imaging data. Compr Psychiatry. 1998 Sep-Oct; 39(5):308-11.
    View in: PubMed
  200. Kinney DK, Yurgelun-Todd DA, Tohen M, Tramer S. Pre- and perinatal complications and risk for bipolar disorder: a retrospective study. J Affect Disord. 1998 Sep; 50(2-3):117-24.
    View in: PubMed
  201. Kinney DK, Levy DL, Yurgelun-Todd DA, Tramer SJ, Holzman PS. Inverse relationship of perinatal complications and eye tracking dysfunction in relatives of patients with schizophrenia: evidence for a two-factor model. Am J Psychiatry. 1998 Jul; 155(7):976-8.
    View in: PubMed
  202. Kwon JS, Shenton ME, Hirayasu Y, Salisbury DF, Fischer IA, Dickey CC, Yurgelun-Todd D, Tohen M, Kikinis R, Jolesz FA, McCarley RW. MRI study of cavum septi pellucidi in schizophrenia, affective disorder, and schizotypal personality disorder. Am J Psychiatry. 1998 Apr; 155(4):509-15.
    View in: PubMed
  203. Salisbury DF, Shenton ME, Sherwood AR, Fischer IA, Yurgelun-Todd DA, Tohen M, McCarley RW. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe. Arch Gen Psychiatry. 1998 Feb; 55(2):173-80.
    View in: PubMed
  204. Pillay SS, Renshaw PF, Bonello CM, Lafer B, Fava M, Yurgelun-Todd DA . A quantitative MRI study of caudate and lenticular gray matter volume in primary unipolar major depression: Relationship to treatment response and clinical severity. Psychiatry Res: Neuroimaging. 1998; 84(2-3):61-74.
  205. Levin JM, Ross MH, Mendelson JH, Kaufman MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF. Reduction in BOLD response to photic stimulation after ethanol administration. Psychiatry Res: Neuroimaging. 1998; 82:135-46.
  206. Frederick BB, Satlin A, Yurgelun-Todd DA, Renshaw PF. In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes. Biol Psychiatry. 1997 Jul 15; 42(2):147-50.
    View in: PubMed
  207. Pillay SS, Yurgelun-Todd DA, Bonello CM, Lafer B, Fava M, Renshaw PF. A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity. Biol Psychiatry. 1997 Jul 15; 42(2):79-84.
    View in: PubMed
  208. Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 1997 Apr 15; 41(8):837-43.
    View in: PubMed
  209. Pope HG, Jacobs A, Mialet JP, Yurgelun-Todd D, Gruber S. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom. 1997; 66(4):179-84.
    View in: PubMed
  210. Ross MH, Yurgelun-Todd DA, Renshaw PF, Maas LC, Mendelson JH, Mello NK, Cohen BM, Levin JM. Age-related reduction in functional MRI response to photic stimulation. Neurology. 1997 Jan; 48(1):173-6.
    View in: PubMed
  211. Woods BT, Yurgelun-Todd D, Goldstein JM, Seidman LJ, Tsuang MT. MRI brain abnormalities in chronic schizophrenia: one process or more? Biol Psychiatry. 1996 Oct 1; 40(7):585-96.
    View in: PubMed
  212. Mialet JP, Pope HG, Yurgelun-Todd D. Impaired attention in depressive states: a non-specific deficit? Psychol Med. 1996 Sep; 26(5):1009-20.
    View in: PubMed
  213. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. Dynamic susceptibility contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry. 1996 May; 153(5):721-4.
    View in: PubMed
  214. Steingard RJ, Renshaw PF, Yurgelun-Todd D, Appelmans KE, Lyoo IK, Shorrock KL, Bucci JP, Cesena M, Abebe D, Zurakowski D, Poussaint TY, Barnes P. Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry. 1996 Mar; 35(3):307-11.
    View in: PubMed
  215. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Ed M, Waternaux C, Cohen BM. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res. 1996 Mar; 19(1):55-9.
    View in: PubMed
  216. Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA. 1996 Feb 21; 275(7):521-7.
    View in: PubMed
  217. Yurgelun-Todd DA, Waternaux CM, Cohen BM, Gruber SA, English CD, Renshaw PF. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry. 1996 Feb; 153(2):200-5.
    View in: PubMed
  218. Yurgelun-Todd DA, Kinney DK, Sherwood AR, Renshaw PF. Magnetic Resonance in Schizophrenia. Semin Clin Neuropsychiatry. 1996 Jan; 1(1):4-19.
    View in: PubMed
  219. Yurgelun-Todd DA, Kinney DK, Sherwood AR, Renshaw PF . Magnetic resonance studies of schizophrenia [Review]. Semin Clin Neuropsychiat. 1996; 1(1):4-19.
  220. Woods BT, Yurgelun-Todd D, Mikulis D, Pillay SS. Age-related MRI abnormalities in bipolar illness: a clinical study. Biol Psychiatry. 1995 Dec 15; 38(12):846-7.
    View in: PubMed
  221. Cohen BM, Yurgelun-Todd D, English CD, Renshaw PF. Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI. Am J Psychiatry. 1995 Dec; 152(12):1801-3.
    View in: PubMed
  222. Kouri E, Pope HG, Yurgelun-Todd D, Gruber S. Attributes of heavy vs. occasional marijuana smokers in a college population. Biol Psychiatry. 1995 Oct 1; 38(7):475-81.
    View in: PubMed
  223. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM. Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA. 1995 Sep 20; 274(11):902-7.
    View in: PubMed
  224. Pope HG, Gruber AJ, Yurgelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend. 1995 Apr; 38(1):25-34.
    View in: PubMed
  225. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry. 1995 Mar; 152(3):444-6.
    View in: PubMed
  226. Maher BA, Manschreck TC, Woods BT, Yurgelun-Todd DA, Tsuang MT. Frontal brain volume and context effects in short-term recall in schizophrenia. Biol Psychiatry. 1995 Feb 1; 37(3):144-50.
    View in: PubMed
  227. Yurgelun-Todd DA, Gruber SA, Cohen BM, Renshaw PF. 1H spectroscopy of the temporal lobes in schizophrenic and bipolar patients. New Prospects in Psychiatry: The Bioclinical Interface. 1995; 481-486.
  228. Woods BT, Brennan S, Yurgelun-Todd D, Young T, Panzarino P. MRI abnormalities in major psychiatric disorders: an exploratory comparative study. J Neuropsychiatry Clin Neurosci. 1995; 7(1):49-53.
    View in: PubMed
  229. Renshaw PF, Yurgelun-Todd DA, Cohen BM . Perils and pitfalls of fMRI: Photic stimulation in subjects with schizophrenia. Macher JP, Crocq MA, Nedelec JF, editors. New Prospects in Psychiatry: The Bioclinical Interface. 1995; 415-9.
  230. Cohen BM, Renshaw PF, Yurgelun-Todd DA. Imaging the mind: Magnetic resonance spectroscopy and functional brain imaging [Invited Editorial]. Am J Psychiatry. 1995; 152(5):655-8.
  231. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Cohen BM. Echo planar MRI of schizophrenics and normal controls during word production. New Prospects in Psychiatry: The Bioclinical Interface. 1995; 487-90.
  232. Kinney DK, Levy DL, Yurgelun-Todd DA, Medoff D, LaJonchere CM, Radford-Paregol M. Season of birth and obstetrical complications in schizophrenics. J Psychiatr Res. 1994 Nov-Dec; 28(6):499-509.
    View in: PubMed
  233. Renshaw PF, Yurgelun-Todd DA, Cohen BM. Greater hemodynamic response to photic stimulation in schizophrenic patients: an echo planar MRI study. Am J Psychiatry. 1994 Oct; 151(10):1493-5.
    View in: PubMed
  234. Kinney DK, Yurgelun-Todd DA, Waternaux CM, Matthysse S. Obstetrical complications and trail making deficits discriminate schizophrenics from unaffected siblings and controls. Schizophr Res. 1994 Apr; 12(1):63-73.
    View in: PubMed
  235. Seidman LJ, Yurgelun-Todd D, Kremen WS, Woods BT, Goldstein JM, Faraone SV, Tsuang MT. Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biol Psychiatry. 1994 Feb 15; 35(4):235-46.
    View in: PubMed
  236. Kinney DK, Yurgelun-Todd DA, Levy DL, Medoff D, Lajonchere CM, Radford-Paregol M. Obstetrical complications in patients with bipolar disorder and their siblings. Psychiatry Res. 1993 Jul; 48(1):47-56.
    View in: PubMed
  237. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurological hard signs in schizophrenia and major mood disorders. J Nerv Ment Dis. 1993 Mar; 181(3):202-4.
    View in: PubMed
  238. Yurgelun-Todd DA, Kinney DK. Patterns of neuropsychological deficits that discriminate schizophrenic individuals from siblings and control subjects. J Neuropsychiatry Clin Neurosci. 1993; 5(3):294-300.
    View in: PubMed
  239. Pope HG, Yurgelun-Todd DA. A family interview study of schizophrenia, schizoaffective disorder, and major mood disorder: updated findings. Europ Psychiatry. 1993; 8:1-5.
  240. Yurgelun-Todd DA, Kinney DK. Perinatal complications are associated with Wisconsin Card Sort Performance in non-schizophrenics: Preliminary findings. Neuropsychiat, Neuropsychol Behav Neurol. 1993; 6(2):77-82.
  241. Matthysse S, Levy DL, Kinney D, Deutsch C, Lajonchere C, Yurgelun-Todd D, Woods B, Holzman PS. Gene expression in mental illness: a navigation chart to future progress. J Psychiatr Res. 1992 Oct; 26(4):461-73.
    View in: PubMed
  242. Matthysse S, Levy DL, Kinney D, Deutsch C, Lajonchere C, Yurgelun-Todd D, Woods B, Holzman PS. Gene expression in mental illness: A navigation chart to future progress. J Psychiatric Res. 1992; 26(4):461-73.
  243. Kinney DK, Yurgelun-Todd DA, Woods BT. Neurologic signs in patients with paranoid and nonparanoid schizophrenia. J Neuropsychiatry Clin Neurosci. 1992; 4(4):447-9.
    View in: PubMed
  244. Woods BT, Kinney DK, Yurgelun-Todd DA. Neurological "hard" signs and family history of psychosis in schizophrenia. Biol Psychiatry. 1991 Oct 15; 30(8):806-16.
    View in: PubMed
  245. Woods BT, Yurgelun-Todd D. Brain volume loss in schizophrenia: when does it occur and is it progressive? Schizophr Res. 1991 Oct; 5(3):202-4.
    View in: PubMed
  246. Kinney DK, Yurgelun-Todd DA, Woods BT. Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res. 1991 Oct; 39(1):45-53.
    View in: PubMed
  247. Keck PE, Pope HG, Hudson JI, McElroy SL, Yurgelun-Todd D, Hundert EM. A controlled study of phenomenology and family history in outpatients with bulimia nervosa. Compr Psychiatry. 1990 Jul-Aug; 31(4):275-83.
    View in: PubMed
  248. Pope HG, Yurgelun-Todd D. Schizophrenic individuals with bipolar first-degree relatives: analysis of two pedigrees. J Clin Psychiatry. 1990 Mar; 51(3):97-101.
    View in: PubMed
  249. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HG, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry. 1990 Feb 1; 27(3):341-52.
    View in: PubMed
  250. Zanarini MC, Frankenburg FR, Pope HG, Hudson JI, Yurgelun-Todd D, Cicchetti CJ. Axis II comorbidity of normal-weight bulimia. Compr Psychiatry. 1990 Jan-Feb; 31(1):20-4.
    View in: PubMed
  251. Levin S, Yurgelun-Todd D, Craft S. Contributions of clinical neuropsychology to the study of schizophrenia. J Abnorm Psychol. 1989 Nov; 98(4):341-56.
    View in: PubMed
  252. Pope HG, Hudson JI, Yurgelun-Todd D. Depressive symptoms in bulimic, depressed, and non-psychiatric control subjects. J Affect Disord. 1989 Jan-Feb; 16(1):93-9.
    View in: PubMed
  253. Hudson JI, Pope HG, Wurtman J, Yurgelun-Todd D, Mark S, Rosenthal NE. Bulimia in obese individuals. Relationship to normal-weight bulimia. J Nerv Ment Dis. 1988 Mar; 176(3):144-52.
    View in: PubMed
  254. Pope HG, Cohen BM, Lipinski JF, Yurgelun-Todd DA. DSM-III criteria for affective disorders and schizophrenia: A preliminary appraisal using family interview findings. Psychiatry and Psychobiology. 1988; 3:159-69.
  255. Hudson JI, Pope HG, Yurgelun-Todd DA. Bulimia and major affective disorder: Experience with 105 patients. Psychiatry and Psychobiology. 1988; 3:37-47.
  256. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D, Frankenburg FR. A controlled family history study of bulimia. Psychol Med. 1987 Nov; 17(4):883-90.
    View in: PubMed
  257. Hudson JI, Pope HG, Yurgelun-Todd D, Jonas JM, Frankenburg FR. A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry. 1987 Oct; 144(10):1283-7.
    View in: PubMed
  258. Pope HG, Frankenburg FR, Hudson JI, Jonas JM, Yurgelun-Todd D. Is bulimia associated with borderline personality disorder? A controlled study. J Clin Psychiatry. 1987 May; 48(5):181-4.
    View in: PubMed
  259. Woods BT, Yurgelun-Todd D, Kinney DK. Relationship of neurological abnormalities in schizophrenics to family psychopathology. Biol Psychiatry. 1987 Mar; 22(3):325-31.
    View in: PubMed
  260. Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd DA . Antidepressant treatment of bulimia: A two-year follow-up study. Hollister LE, Lasagna L, editors. The Year Book of Drug Therapy Annual. 1987; 420.
  261. Kinney DK, Woods BT, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. II. Neurologic and psychiatric findings in relatives. Arch Gen Psychiatry. 1986 Jul; 43(7):665-8.
    View in: PubMed
  262. Woods BT, Kinney DK, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. I. Comparison of schizophrenic, bipolar, and substance abuse patients and normal controls. Arch Gen Psychiatry. 1986 Jul; 43(7):657-63.
    View in: PubMed
  263. Pope HG, Herridge PL, Hudson JI, Fontaine R, Yurgelun-Todd D. Treatment of bulimia with nomifensine. Am J Psychiatry. 1986 Mar; 143(3):371-3.
    View in: PubMed
  264. Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd D. Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol. 1985 Dec; 5(6):320-7.
    View in: PubMed
  265. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D. Treatment of anorexia nervosa with antidepressants. J Clin Psychopharmacol. 1985 Feb; 5(1):17-23.
    View in: PubMed
  266. Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd DA . Antidepressant treatment of bulimia: A research update. Kaye W, Gwitsman H, editors. Physiology and Treatment of Bulimia in Normal Weight Women. 1985; 119-31.
  267. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D. Treatment of anorexia nervosa and antidepressants. J Clin Psychopharmacol. 1985; 5(1):17-23.
  268. Pope HG, Hudson JI, Poskanzer DC, Yurgelun-Todd D. Familial hyperkalemic periodic paralysis and bipolar disorder: a linkage and treatment study. Biol Psychiatry. 1984 Oct; 19(10):1449-59.
    View in: PubMed
  269. Pope HG, Hudson JI, Yurgelun-Todd D. Anorexia nervosa and bulimia among 300 suburban women shoppers. Am J Psychiatry. 1984 Feb; 141(2):292-4.
    View in: PubMed
  270. Pope HG, Hudson JI, Poskanzer DA, Yurgelun-Todd D. Familial hyperkalemic periodic paralysis and manic-depressive illness: A linkage and treatment study. Biol Psychiatry. 1984; 19(10):1449-59.
  271. Frankenburg FR, Yurgelun-Todd D. Dressing disorder. Am J Psychiatry. 1984 Jan; 141(1):147.
    View in: PubMed
  272. Pope HG, Hudson JI, Yurgelun-Todd DA, Hudson MS. Prevalence of anorexia nervosa and bulimia in three student populations. Internatl J of Eating Disorders. 1984; 4:45-51.
  273. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D. Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res. 1983 Aug; 9(4):345-54.
    View in: PubMed
  274. Pope HG, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry. 1983 May; 140(5):554-8.
    View in: PubMed
  275. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D. Family history study of anorexia nervosa and bulimia. Br J Psychiatry. 1983 Apr; 142:428-9.
    View in: PubMed
  276. Pope HG, Ionescu-Pioggia M, Yurgelun-Todd D. Migration and manic-depressive illness. Compr Psychiatry. 1983 Mar-Apr; 24(2):158-65.
    View in: PubMed
  277. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D. Family history study of anorexia nervosa and bulimia. Br J Psychiatry. 1983 Feb; 142:133-8.
    View in: PubMed
  278. Tolbert LP, Morest DK, Yurgelun-Todd DA. The neuronal architecture of the anteroventral cochlear nucleus of the cat in the region of the cochlear nerve root: horseradish peroxidase labelling of identified cell types. Neuroscience. 1982; 7(12):3031-52.
    View in: PubMed
  279. Morest DK, Ard MD, Yurgelun-Todd DA. Degeneration in the central auditory pathways after acoustic deprivation or over-stimulation. Anatomical Record. 1978; 193(3):750.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Yurgelun-Todd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department